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Purpose: The aim of this study was to formulate the hexane extract of the leaves of Morinda 
morindoides (Baker) Milne-Redh (Rubiaceae) as soap and evaluate its antifungal activity against fungal 
isolates of human origin. 
Method: The hexane extract of Morinda morindoides was incorporated as an antifungal agent in soap 
(SMM) and tested against 4 strains of dermatophytes (Candida albicans, Trichophyton rubrum, 
Trichophyton mentagrophytes and Aspergillus fumigatus) using basic soap (BS) as control. Agar dilution 
method at serial concentrations ranging from 125 mg/ml to 3.9 mg/ml was used for the determination of 
the antimicrobial parameters - MIC (minimum inhibitory concentration) and IC50 (concentration 
producing 50 % inhibition) for these strains. 
Result: The growth of all fungal strains tested was inhibited by the Morinda morindoides extract soap 
(SMM) at MIC of 31.25 mg/ml. On the other hand, basic soap (control) inhibited Candida albicans at 
MIC of 125 mg/ml and at MIC of 62.50 mg/ml for the other 3 strains tested. Thus, SMM showed stronger 
antifungal activity against the strains tested than the control (basic soap).  
Conclusion: The hexane extract of Morinda morindoides leaves incorporated in soap exerted antifungal 
activity against the fungal strains tested. Thus, this soap formulation may find use in the treatment of 
dermatomycoses. 
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INTRODUCTION 
 
The rapid development of multiresistant 
bacterial and fungal strains of clinically 
important pathogens has spurred scientists to 
attempt to develop newer broad spectrum 
antimicrobial agents [1]. High cost of new 
generation antibiotics has directed a 
searchlight on less costly sources of effective 
antimicrobial substances such as plants. A 
number of herbs with significant antimicrobial 
activity have been reported in the literature
 
[2]. The importance of African traditional 
medicine in the management of diseases has 
long been established
 
[3]. In Ivory Coast, 
traditional medicines are increasingly sought 
from tradomedical practitioners and herbalists 
for the treatment of various diseases. Among 
the remedies used, plant drugs constitute an 
important part. A number of scientific 
investigations have highlighted the 





Morinda morindoides (Baker) Milne-Redh 
(Rubiaceae) is found at the borders of 
tropical forests. In the Democratic Republic of 
Congo, M. morindoides has long been used 
in villages and towns in the treatment of 
some parasitic diseases; the leaf extracts of 
the plant have been shown to possess 
antiprotozoal activity particularly against 
Entamoeba histolytica as well as 
antirheumatic properties
 
[5]. The decoction of 
the leaves has also been used for the 
treatment of malaria, intestinal worms, and 
amoebiasis [6]. M. morindoides is well known 
in the traditional medical practice of the west 
central part of Ivory Coast. It is commonly 
called Zêlékelé in the local language of ‘Bété’ 
where it is used as an antimicrobial agent
 
where the leaves are employed in traditional 
medicine to treat diarrheoa [7]. 
 









have been isolated from the butanol and ethyl 
acetate fractions of the plant leaf. In addition, 
a total of eight iridoid glycosides, among 
which are gaertneroside, gaertneric acid, 
methoxy-gaertneroside and epoxygaert-
neroside, were also isolated from the same 
fractions by Cimanga et al [5].  
 
The aim of this study was to formulate the 
hexane extract of the leaves of Morinda 
morindoides (Baker) Milne-Redh (Rubiaceae) 
as soap and to evaluate the in vitro antifungal 
activity of the soap against fungal isolates of 
human origin, namely, Candida albicans, 
Trichophyton rubrum, Trichophyton menta-






The leaves of Morinda morindoides 
(Rubiaceae) were collected from Daloa 
(central west region of Ivory Coast) in June 
2006. The plant was identified and 
authenticated by Pr AKE ASSI, of the 
Department of Botany, University of Cocody. 
A voucher specimen (no. 17710) of the plant 
was deposited in the herbarium of the 
National Floristique Center of the University 
of Cocody-Abidjan.  
 
Preparation of hexane extract 
 
The leaves of M. morindoides were cleaned 
of extraneous matter, air-dried at room 
temperature for 7 days and ground into a fine 
powder. The powdered material (100 g) was 
extracted with 250 ml of hexane (Merck, 
Darmstadt, Germany) for 24 h using a 
Soxhlet extractor. The extract was filtered 
with Whatman filter paper no. 1, and the 
filtrate was evaporated under vacuum in a 
rotary evaporator (Buchi) at 55 °C. The 
extract obtained was used as antifungal 
agent to make soap. 
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Preparation of soap  
 
Soap containing the extract was prepared by 
incorporating the extract into basic soap 
prepared as follows. 60 g of sodium 
hydroxide was dissolved in 170 ml of water 
and allowed to cool to 35 – 40 °C. Also, 450 g 
of a mixture (w/w) of coconut oil (Sicor, Ivory 
Coast) and palm oil (Blohorn, Ivory Coast) 
were heated in a water bath at 55 °C. Both 
the aqueous and oily phases were mixed 
together. To 90 g of the soap formed, 10 g of 
the extract was added and gently stirred to 
form a viscous gel.  The remainder of the 
soap (590 g) was also gently stirred to form a 
viscous gel which served as control. The two 
soap formulations were poured into separate 
soap moulds. Two days later, the two 
solidified products were removed from the 





The antifungal activity of the soap containing 
the extract was evaluated against 4 strains of 
fungi provided by the Medical Sciences 
Department of Cocody University, Abidjan, 
Ivory Coast. These strains were clinical 
isolates of the following dermatophyte 
species: Candida albicans 3076/PV/06/04/00, 
Trichophyton rubrum 2630/D/24/07/99, 
Trichophyton mentagrophytes 13801/D/19/ 





Antifungal activity was assessed according to 
the agar dilution method
 
[9] on Sabouraud 
agar (ref 695771, Dardilly Admy 42310, 
Oxoid Ltd). The extract soap and the basic 
soap (control) were incorporated into the 
growth medium in tubes to give serial two-
fold dilutions. The resulting concentrations 
ranged from 125.0 to 3.9 mg/ml. A tube, 
containing nutrient broth only, seeded with 
test organism was served as growth control. 
The tubes were inoculated with a 
microorganism suspension with a density of 
10
5 
cells/ml and then incubated at 30 °C for 5 
days. All experiments were performed in 
triplicate. Antimicrobial parameters (MIC and 
IC50) were determined after counting the 
colony of fungi in the tubes for each series. 
The total score of colony of the control tube 
was considered as 100 %. MIC (minimal 
inhibitory concentration) was defined as the 
lowest concentration that produced no visible 
fungal growth after the incubation period 
while IC50 was defined as the concentration 
that produced 50 % inhibition. IC50 values 
were computed from the survival curves for 
fungi strains using of Prism
®
 version 5.01 




The data were analyzed by one-way ANOVA 
followed by Dunnett’s t-test using Instat
®
 
(Graph Pad software, U.S.A). Results were 
considered statistically significant at 95 % 




The antifungal effects of test soap and control 
on the four fungi strains are presented in 
Table 1. The values were used for the 
determination of MIC and IC50, and the data 
for these parameters are recorded in Table 2. 
The MIC data indicate that C. albicans was 
inhibited at a concentration of 125 mg/ml for 
the basic soap (control) compared with 31.25 
mg/ml for the test soap (SMM) containing the 
extract. The other three fungi (T. rubrum, T. 
mentagrophytes and A. fumigatus) were each 
also inhibited at a concentration of 31.25 
mg/ml (SMM) but at a higher concentration of 
62.5 mg/ml by the control (BS). C. albicans 
presented the highest IC50 of 10.41±0.01 for 
BS and 6.5±0.01 for SMM while the other 
fungal strains showed lower IC50 values 
ranging from 2.44±0.01 to 2.78±0.01 for SMM 
and 3.25±0.01 to 6.50±0.01 for BS.  
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Table1: Comparative antifungal activities of the soap containing Morinda morindoides (SMM) extract and 
basic soap (BS, control) against four fungal strains (mean ± SEM, n = 3, p < 0.05 
 
Soaps  concentrations (mg/ml) 
Fungus           Soaps      0                3.90          7.81           15.62          31.25         62.5              125 
Candida            BS        100.0±1.7    90.0±1.7    60.0±1.7    30.0±0.6     5.0±0.6       2.0±0.6           0 
albicans              SMM     100.0±1.0     70.0±1.2     40.0±0.6      6.0±0.6            0  
 
Trichophyton       BS        100.0±2.0     40±1.7        30.0±2.1     10.0±0.6      5.0±0.6          0 
rubrum                SMM     100.0±1.7     30.0±1.2    10.±1.2        3.0±0.6            0 
 
Trichophyton       BS        100.0±1.2     30.0±0.6     20.0±0.6      5.0±0.6       2.0±0.6          0 
mentagrophytes  SMM    100.0±1.7      20.0±1.2    15.0±1.7      3.0±1.2           0 
 
Aspergillus          BS        100.0±2.1     70.0±0.6      30.0±1.2     15.0±1.2     5.0±0.6        2.0±0.6         0 
fumigatus            SMM    100.0±1.0      30.0±0.6     10.0±1.2      2.0±0.6           0 
 
 
Table 2: Antifungal parameters for the test soap containing Morinda morindoides extract (SMM) 
and basic soap (BS, control) against four fungi strains (mean±SEM)   
 













Candida albicans                             10.41±0.01       125  6.50±0.01          31.25 
Trichophyton rubrum                        3.25±0.01         62.50                2.78±0.01          31.25 
Trichophyton mentagrophytes          2.78±0.01         62.50                2.44±0.01          31.25 





To evaluate the antifungal activity of the basic 
soap formulation of the hexane extract of 
Morinda morindoides, we compared its 
activity with that of basic soap (BS) alone 
which served as control. For each type of 
soap, the results showed a decrease in the 
number of colonies with increase in the 
extract concentration of the soap. The results 
showed that T. mentagrophytes was the most 
sensitive strain while C. albicans was the 
most resistant, irrespective of the soap type. 
The other two strains, T. rubrum and A. 
fumigatus, presented intermediate sensitivity 
in relation to the other two strains. The MIC 
and IC50 data also indicate that of the two 
soap formulations, the one containing the 
plant extract (SMM) was more active and 
inhibited more effectively the growth of the 
test strains. 
To the best of our knowledge, this is the first 
time the antifungal activity of the hexane 
extract of M. morindoides has been reported. 
This observation may be attributed to the 
nature of its biologically active contents. The 
antifungal activity may be due mostly to the 
lypophilic metabolites in the extract since a 
lipophilic solvent was used for the extraction. 
Phytochemical screening of M. morindoides 
by Cimanga et al [8] yielded ten flavonoïds, 






7-O-glucoside, and luteolin-7-O-glucoside), 
amongst other compounds. These flavonoïds 
are likely to have played a major role in the 
antifungal activity of the extract since they are 
lipophilic due to the presence of a phenyl 
chain. The lipophilic nature of these 
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compounds would facilitate induction of 
antifungal activity by interaction with the cell 
membranes of the fungi. In addition, 
flavonoids exhibit antioxidant properties
 
[9] 
which are believed to be responsible for the 
inhibitory effects exerted on several 
enzymes. Thus, the characteristics of the 
constituents, as outlined in the foregoing, 
might have been responsible for the 
antifungal activity of the soaps containing the 




The fungal strains used in this study are 
mostly responsible for superficial mycoses. 
However, treatments of these infections are 
sometimes ineffective. This study has shown 
that incorporation of the hexane extract of M. 
morindoides leaves in soap exerted 
antifungal activity against dermatophytes, 
some of which are the most frequent species 
implicated in dermatomycoses in Ivory Coast. 
Further research is needed to determine the 
toxicological profile of this soap formulation 
and as well as develop it further for 
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